Philippe Gerald Pierre HARTEMANN

Prof. Dr. Philippe Gerald Pierre HARTEMANN

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Water Research
Verified
Journal Article
Closed access
CSChristian Steinberg
Christian Steinberg
JLJulie Laurent
Julie Laurent
VEVéronique Edel-Hermann
Véronique Edel-Hermann
MBMarie Barbezant
Marie Barbezant
NSNathalie Sixt
Nathalie Sixt
MSMarc Sautour
Marc Sautour

31 July 2024 in Water
Verified
Journal Article
Open access
PDF file
Vincenzo Romano SpicaVincenzo Romano Spica
Vincenzo Romano Spica
PBPaola Borella
Paola Borella
ABAgnese Bruno
Agnese Bruno
CCCristian Carboni
Cristian Carboni
MEMartin Exner
Martin Exner
Federica ValerianiFederica Valeriani
Federica Valeriani
Legionella is the pathogen that causes Legionnaires’ disease, an increasingly prevalent and sometimes fatal disease worldwide. In 2021, 97% of cases in Europe were caused by Legionella pneumophila. We present a mathematical model that can be used by public health officials to assess the effectiveness and efficiency of different Legionella monitoring and control strategies to inform government requirements to prevent community-acquired Legionnaires’ disease in non-hospital buildings. This simulation model was built using comprehensive data from multiple scientific and field-based sources. It is a tool for estimating the relative economic and human costs of monitoring and control efforts targeting either L. pneumophila or Legionella species and was designed to analyze the potential application of each approach to specific building classes across Italy. The model results consistently showed that targeting L. pneumophila is not only sufficient but preferable in optimizing total cost (direct and economic) for similar human health benefits, even when stress-tested with extreme inputs. This cost–benefit analytical tool allows the user to run different real-life scenarios with a broad range of epidemiological and prevalence assumptions across different geographies in Italy. With appropriate modifications, this tool can be localized and applied to other countries, states, or provinces.

10 February 2010
Verified
Journal Article
Open access
AKAxel Kramer
Axel Kramer
HWHans Wagenvoort
Hans Wagenvoort
CAChristina Ahrén
Christina Ahrén
IDInka Daniels-Haardt
Inka Daniels-Haardt
PHPhilippe Gerald Pierre HARTEMANN
Philippe Gerald Pierre HARTEMANN
OAOjan Assadian
Ojan Assadian
The prevalence of health-care associated infections caused by multi-drug resistant organisms has significantly increased over the past decade. Among these organisms, Methicillin-resistant Staphylococcus aureus (MRSA) plays a prominent and increasing role. Because of consequences for patients and the economic burden in course of prolonged treatment following MRSA infections and additional indirect costs for e.g. isolation or antiseptic treatment, this trend will further damage European health-care systems.In 2006, a workshop was initiated at the 8(th) International Congress of the German Society of Hospital Hygiene held in Berlin. The aim of this workshop was to give an overview of the current situation of MRSA in selected European countries and to elaborate on potential strategies to prevent MRSA-infections and dissemination. A questionnaire encompassing 20 questions addressed topics such as epidemiology, current measures and future prospects was distributed to representatives from various European countries and Japan. A variety of widely different answers was obtained. It was shown that in all countries prevalence of MRSA is on a rising tide. This trend is observable in all European countries, albeit less strong in The Netherlands, Slovenia, France, Austria and Scandinavian countries. It was conclude that prevention strategies in a united and expanding European Community will become of utmost importance and that rapid screening strategies, e.g. PCR, might be of assistance in such an approach. A potential strategy to improve infection control measures could be the requirement of health-insurance providers to sign contracts only with hospitals able to proof having an infection control management in place.

9 December 2013 in BMC Public Health
Verified
Journal Article
Open access
PDF file
PHPaul Hunter
Paul Hunter
HRHelen Risebro
Helen Risebro
MYMarie Yen
Marie Yen
HLHélène Lefebvre
Hélène Lefebvre
CLChay Lo
Chay Lo
FJFrançois Jaquenoud
François Jaquenoud
Despite claims that the Millennium Development Goals (MDG) targets on access to safe drinking water have been met, many 100 s of millions of people still have no access. The challenge remains how to provide these people and especially young children with safe drinking water. We report a longitudinal study designed to assess the effectiveness of an intervention based on provided treated drinking water in containers on self-reported diarrhoea in children. The intervention was “1001 fontaines pour demain” (1001 F) is a non-governmental not for profit organization (created in 2004 and based in Caluire, France) that helps local entrepreneurs treat package, and sell safe drinking water. Cases and controls were chosen at village and household level by propensity score matching Participants were visited twice a month over six months and asked to complete a diarrhoea health diary. In total 4275 follow-up visits were completed on 376 participants from 309 homes. Diarrhoea was reported in 20.4% of children on each visit, equating to an incidence rate estimate of 5.32 episodes per child per year (95% confidence interval = 4.97 to 5.69). Compared to those drinking 1001 F water, children drinking surface water were 33% (95% CI -1 to 17%), those drinking protected ground water were 62% (95% CI 19 to 120%) and those drinking other bottled water 57% (95% CI 15 to 114%) more likely to report diarrhoea. Children drinking harvested rainwater had similar rates of diarrhoea to Children drinking 1001 F water. Our study suggests that 1001 F water provides a safer alternative to groundwater or surface water. Furthermore, our study raises serious concerns about the validity of assuming protected groundwater to be safe water for the purposes of assessing the MDG targets. By contrast our study provides addition evidence of the relative safety of rainwater harvesting.

1 April 2006 in Medecine Et Maladies Infectieuses
Verified
Journal Article
Closed access
Cécile PhilippeCécile Philippe
Cécile Philippe
MBM.F. Blech
M.F. Blech
PHPhilippe Gerald Pierre HARTEMANN
Philippe Gerald Pierre HARTEMANN

1 May 2019 in International Journal of Hygiene and Environmental Health
Verified
Journal Article
Closed access
KSKaren Setty
Karen Setty
JLJean-Francois Loret
Jean-Francois Loret
SCSophie Courtois
Sophie Courtois
CHCharlotte Christiane Hammer
Charlotte Christiane Hammer
PHPhilippe Gerald Pierre HARTEMANN
Philippe Gerald Pierre HARTEMANN
Jamie BartramJamie Bartram
Jamie Bartram